Login to Your Account


After three days of a partial shutdown, it looks like it’s back to business as usual for the U.S. government – sort of.

With the prospect of a U.S. federal government shutdown appearing ever more likely Friday, the potential tolls that action might take on the FDA, NIH and other federal elements crucial to industry's forward momentum became clearer in some respects, but not others.

Two months ahead of its PDUFA date, La Jolla Pharmaceutical Co. has won FDA approval for a new vasopressor capable of increasing blood pressure in adults with septic or other distributive shock.

More U.S. Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: